| Dr-MurderX vs Kazuya | 44–23 | 65.67% |
| Dr-MurderX vs Jin | 39–25 | 60.94% |
| Dr-MurderX vs King | 36–17 | 67.92% |
| Dr-MurderX vs Yoshimitsu | 32–20 | 61.54% |
| Dr-MurderX vs Paul | 30–18 | 62.50% |
| Dr-MurderX vs Dragunov | 34–14 | 70.83% |
| Dr-MurderX vs Bryan | 22–16 | 57.89% |
| Dr-MurderX vs Devil Jin | 15–21 | 41.67% |
| Dr-MurderX vs Hwoarang | 24–11 | 68.57% |
| Dr-MurderX vs Victor | 24–10 | 70.59% |
| Dr-MurderX vs Asuka | 20–10 | 66.67% |
| Dr-MurderX vs Reina | 19–9 | 67.86% |
| Dr-MurderX vs Law | 19–8 | 70.37% |
| Dr-MurderX vs Lili | 22–5 | 81.48% |
| Dr-MurderX vs Nina | 14–13 | 51.85% |
| Dr-MurderX vs Feng | 15–8 | 65.22% |
| Dr-MurderX vs Alisa | 14–8 | 63.64% |
| Dr-MurderX vs Lars | 9–12 | 42.86% |
| Dr-MurderX vs Lidia | 8–13 | 38.10% |
| Dr-MurderX vs Jun | 8–12 | 40.00% |
| Dr-MurderX vs Steve | 11–7 | 61.11% |
| Dr-MurderX vs Xiaoyu | 11–6 | 64.71% |
| Dr-MurderX vs Raven | 6–11 | 35.29% |
| Dr-MurderX vs Azucena | 7–7 | 50.00% |
| Dr-MurderX vs Lee | 5–5 | 50.00% |
| Dr-MurderX vs Jack-8 | 4–5 | 44.44% |
| Dr-MurderX vs Zafina | 4–5 | 44.44% |
| Dr-MurderX vs Leroy | 7–2 | 77.78% |
| Dr-MurderX vs Eddy | 8–1 | 88.89% |
| Dr-MurderX vs Leo | 3–5 | 37.50% |
| Dr-MurderX vs Shaheen | 6–2 | 75.00% |
| Dr-MurderX vs Claudio | 4–0 | 100.00% |
| Dr-MurderX vs Kuma | 2–2 | 50.00% |
| Dr-MurderX vs Panda | 2–2 | 50.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.